These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 39105433)

  • 1. Prognostic Impact of Neoadjuvant Chemotherapy in Localized or Locoregionally Advanced Gallbladder Cancer: A Population-Based and Propensity Score Matched SEER Analysis.
    Xiong YC; Yang ZY; Gong A; Wu ZY; Liu SL; Zhu YD; Song XL; Chu BF; Wu XS; Gong W
    Cancer Control; 2024; 31():10732748241271682. PubMed ID: 39105433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
    Ozer M; Goksu SY; Sanford NN; Porembka M; Khurshid H; Ahn C; Maxwell MC; Beg MS; Kazmi SM
    JAMA Netw Open; 2022 Feb; 5(2):e2146912. PubMed ID: 35171262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced gallbladder cancer: A SEER-based study.
    Mao W; Deng F; Wang D; Gao L; Shi X
    Cancer Med; 2020 Jan; 9(1):141-150. PubMed ID: 31721465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database.
    Shang Y; Wang X; Liu Y; Cheng W; Duan Y; Fang Z; Liu J; Kong F; Wang T; Yu T; Hu A; Zhang J; Zhang H; Li M; Rong Z; Li Y; Shakila SS; Li X; Feng J; Ma F; Guo B
    Breast Cancer; 2024 Jul; 31(4):684-694. PubMed ID: 38643430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of surgery on survival of elderly patients with gallbladder cancer: A propensity score matching analysis of the SEER database.
    Xu X; Wang J; Duan Q
    Front Oncol; 2023; 13():1083618. PubMed ID: 36937413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival benefits of postoperative radiotherapy in patients with cT
    Yang J; Zhao J; Chang H; Yan L; Zhang J; Liu H; Ning P
    BMC Womens Health; 2024 Jun; 24(1):324. PubMed ID: 38834997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.
    Geng ZM; Cai ZQ; Zhang Z; Tang ZH; Xue F; Chen C; Zhang D; Li Q; Zhang R; Li WZ; Wang L; Si SB
    World J Gastroenterol; 2019 Oct; 25(37):5655-5666. PubMed ID: 31602165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysis.
    Chambers LM; Jia X; Rose PG; AlHilli M
    Gynecol Oncol; 2021 Feb; 160(2):405-412. PubMed ID: 33221023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of neoadjuvant chemotherapy in "locally advanced/borderline resectable" gallbladder cancer: the need to define indications.
    Chaudhari VA; Ostwal V; Patkar S; Sahu A; Toshniwal A; Ramaswamy A; Shetty NS; Shrikhande SV; Goel M
    HPB (Oxford); 2018 Sep; 20(9):841-847. PubMed ID: 29706425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefits of adjuvant chemotherapy for patients with residual pathologic disease after neoadjuvant chemotherapy and surgery for locally advanced esophageal squamous cell carcinoma.
    Lu H; Liu JF; Rong Y; Liu XB; Wang Y
    J Gastrointest Surg; 2024 Jun; 28(6):867-869. PubMed ID: 38570232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database.
    Bao Y; Yang X; Men Y; Kang J; Sun X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
    Thorac Cancer; 2022 Feb; 13(3):404-411. PubMed ID: 34907665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis.
    Chen X; Liu G; Wang K; Chen G; Sun J
    Oncotarget; 2017 Jul; 8(29):47831-47840. PubMed ID: 28599299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
    Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
    Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
    Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lymphadenectomy on the prognosis for N0 gallbladder carcinoma patients: A study based on SEER database.
    Wu B; Shen Y; Chen X; Wang X; Zhong Z
    Cancer Med; 2021 Oct; 10(20):7136-7143. PubMed ID: 34519168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer.
    Sirohi B; Mitra A; Jagannath P; Singh A; Ramadvar M; Kulkarni S; Goel M; Shrikhande SV
    Future Oncol; 2015; 11(10):1501-9. PubMed ID: 25963427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer - A systematic review.
    Hakeem AR; Papoulas M; Menon KV
    Eur J Surg Oncol; 2019 Feb; 45(2):83-91. PubMed ID: 30287098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease.
    Li J; Ning NY; Rao QX; Chen R; Wang LJ; Lin ZQ
    BMC Cancer; 2017 Aug; 17(1):517. PubMed ID: 28774279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic effect of residual tumor for advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy or primary debulking surgery.
    Yang SP; Chen JX; Xu JY; Lei J; Wu SG; Zhou J
    Cancer Med; 2022 Jul; 11(14):2836-2845. PubMed ID: 35274489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.